Financial Life Planners Buys New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Financial Life Planners acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 156 shares of the medical equipment provider’s stock, valued at approximately $81,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at $82,517,000. Exome Asset Management LLC grew its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. Consolidated Planning Corp raised its holdings in Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after buying an additional 114,149 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,843 shares of company stock worth $15,357,560 in the last ninety days. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Down 1.4 %

Shares of NASDAQ:ISRG opened at $571.88 on Monday. The company’s 50 day moving average price is $550.40 and its two-hundred day moving average price is $510.02. The firm has a market cap of $203.69 billion, a PE ratio of 89.22, a PEG ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research analyst reports. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Finally, Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.